NCT06920069 Study of Concomitant Administration of the sIPV and DTaP or MMR Status NOT_YET_RECRUITING Phase PHASE4
NCT06855160 A Study on the Immune Response and Safety of an Investigational Chickenpox Vaccine and a Marketed Measles, Mumps and Rubella Vaccine When Administered as Intramuscular Injection to Healthy Children 12 to 15 Months of Age Status RECRUITING Phase PHASE3
NCT06806137 A Study on the Immune Response and Safety of the Second Dose of an Investigational Chickenpox Vaccine When Given to Healthy Children 3 Months After a First Dose at 12 to 15 Months of Age Status RECRUITING Phase PHASE3
NCT06740630 A Study on the Immune Response and Safety of an Investigational Chickenpox Vaccine When Given to Healthy Children 12 to 15 Months of Age Status RECRUITING Phase PHASE3
NCT04475081 Use of a Live Attenuated Vaccine as an Immune-based Preventive Against COVID-19-associated Sepsis Status COMPLETED Phase PHASE3
NCT03853785 Efficacy of Intralesional MMR Vaccine,Intralesional Candidal Antigen&Topical Podophyllin in Treatment of Genital Warts Status UNKNOWN Phase PHASE3
NCT03547271 Immunogenicity and Safety Study of a Quadrivalent Meningococcal Conjugate Vaccine When Co-administered With Routine Pediatric Vaccines in Healthy Infants and Toddlers in Europe Status COMPLETED Phase PHASE3
NCT02253407 Safety & Immunogenicity of MMR Vaccine by DSJI to That by Needle-Syringe in 15-18 Months Old Children Status COMPLETED Phase PHASE4
NCT01777529 Comparative Study of the Immunogenicity of MMR (Measles, Mumps and Rubella) Single Dose and Multidose Presentations Status COMPLETED Phase PHASE4
NCT01553279 Immunogenicity and Safety of V419 (PR51) in Combination With MCC in Infants and Toddlers (V419-011) Status COMPLETED Phase PHASE3
NCT00962819 Measles, Mumps, and Rubella (MMR) Immunity in College Students Status COMPLETED Phase N/A